Literature DB >> 28723462

Against the Role of Inflammatory Markers in Renal Cell Carcinoma Prognosis: The Missing Link Between Evidence of Association and Clinical Applicability.

Alessandro Larcher1, Paolo Dell'Oglio2, Andrea Salonia2, Umberto Capitanio2.   

Abstract

Although an association between inflammatory markers (IMs) and renal cell carcinoma (RCC) prognosis has been proven, how to translate such information into treatment strategy has not been determined. The strongest argument against the use of IMs in the management of patients diagnosed with RCC is the missing link between evidence of association and clinical applicability.
Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Year:  2016        PMID： 28723462     DOI： 10.1016/j.euf.2016.02.015

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN： 2405-4569


  1 in total

1.  Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell carcinoma.

Authors:  Fabio Muttin; Angela Pecoraro; Alessandro Larcher; Paolo Dell'Oglio; Alessandro Nini; Francesco Cianflone; Francesco Trevisani; Federico Dehò; Alberto Briganti; Andrea Salonia; Francesco Montorsi; Roberto Bertini; Umberto Capitanio
Journal:  World J Urol       Date:  2018-07-25       Impact factor: 4.226
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.